Financials

v3.24.1
BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:        
Cash and cash equivalents $ 6,760 $ 8,096 $ 2,937  
Restricted cash 13 13 196  
Receivables 46 26 36  
Notes receivable 1,000 1,500  
Inventories (0) 106  
Prepaid expenses and other current assets 199 244 314  
Discontinued operations - current assets 20 14  
Total current assets 8,018 9,899 3,603  
Property and equipment, net 5 6 224  
Other assets 48  
Operating lease right-of-use asset 63 94 183  
Total assets 8,086 9,999 4,058  
Current liabilities:        
Accounts payable 348 407 695  
Note payable to related party 500 500  
Other accrued liabilities 519 790 1,488  
Operating lease liability, current 65 97 122  
Deferred grant revenue 12 12 196  
Discontinued operations - current liabilities 60 129  
Total current liabilities 1,444 1,866 2,630  
Operating lease liability, non-current 65  
Total liabilities 1,444 1,866 2,695  
Stockholders’ equity:        
Preferred stock, at amounts paid-in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at December 31, 2023 and no shares issued and outstanding at December 31, 2022. 1 1  
Common stock, at amounts paid-in, $0.001 par value per share; 225,000,000 shares authorized 781,503 and 750,815 shares issued and outstanding at December 31, 2023 and 2022, respectively. 1 15 1  
Additional paid-in capital 398,470 398,383 387,623  
Accumulated deficit (391,830) (390,266) (386,261)  
Total stockholders’ equity 6,642 8,133 1,363 $ 5,138
Total liabilities and stockholders’ equity $ 8,086 $ 9,999 $ 4,058  

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL
v3.24.1
STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Total revenues $ 184 $ 557
Operating expenses:    
Research and development 1,913 4,758
General and administrative 5,548 6,034
Total operating expenses 7,461 10,792
Loss from operations (7,277) (10,235)
Other income (expense):    
Interest income, net 5 53
Other expense, net (52) (24)
Gain on asset sale 1,755
Other income, net 1,708 29
Net loss $ (5,569) $ (10,206)
Basic net loss per common share $ (7.41) $ (15.19)
Diluted net loss per common share $ (7.41) $ (15.19)
Weighted average shares used in computing basic net loss per common share 752 672
Weighted average shares used in computing diluted net loss per common share 752 672
License and Service [Member]    
Total revenues $ 1 $ 60
Grant [Member]    
Total revenues $ 183 $ 497

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL
v3.24.1
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (5,569) $ (10,206)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 112 196
Gain on sale of assets (1,755)
Stock-based milestone payment 50
Stock-based compensation 1,013 947
Amortization of restricted stock 25 450
Other (2) 2
Changes in operating assets and liabilities:    
Receivables (10) 76
Inventory 187
Prepaid expenses and other assets 177 164
Accounts payable (476) (751)
Other accrued liabilities (423) 801
Deferred revenue (184) (99)
Net cash used in operating activities (7,092) (8,183)
Cash flows from investing activities:    
Cash proceeds from sale of assets 734
Purchases of furniture and equipment (2)
Net cash provided by investing activities 732
Cash flows from financing activities:    
Proceeds from equity offerings 4,980
Proceeds from issuance of preferred stock 9,500
Proceeds from short-term loans 750
Payments on short-term loans (250)
Proceeds from the exercise of warrants 4
Net cash provided by financing activities 10,000 4,984
Net change in cash, cash equivalents and restricted cash 3,640 (3,199)
Cash, cash equivalents and restricted cash at beginning of year 3,133 6,332
Cash, cash equivalents and restricted cash at end of year 6,773 3,133
Supplemental disclosure of cash flow information:    
Interest paid 21
Inventory transferred with sale of assets 106
Property and equipment, net, transferred with sale of assets 109
Notes receivable received in connection with sale of assets 1,000
Other accrued liabilities transferred with sale of assets 236
Other accrued liabilities related to stock-based compensation 310
Cash and cash equivalents 6,760 2,937
Restricted cash 13 196
Cash, cash equivalents and restricted cash as shown in the statements of cash flows $ 6,773 $ 3,133

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL